Loading...
 

Volume 35, Issue 1, March 2024



Sign in to download the Issue in PDF format.

Back to the list
Mediterr J Rheumatol 2024;35(1):73-82
Article Links
From Sand to Excellence: A Deep Dive into Abu Dhabi's Rheumatology Landscape
Khalid A. Alnaqbi1,2, Fahad Fazal3, Rajaie Namas4
Authors Information

1Division of Rheumatology, Tawam Hospital, Al Ain, United Arab Emirates

2Internal Medicine Department, College of Medicine & Health Sciences, United Arab Emirates

3Rheumatology Department, Mediclinic, Al Ain, United Arab Emirates

4Division of Rheumatology, Department of Internal Medicine, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates

KA Alnaqbi, F Fazal, R Namas

Keywords: Abu Dhabi, rheumatology, SEHA Company, PureHealth, medical tourism, research
References
  1. Abu Dhabi Statistics Centre. https://scad.gov.ae [Accessed 1 October 2023].
  2. Abu Dhabi: The Official Portal of the UAE Government. https://u.ae/en/about-the-uae/the-seven-emirates/abu-dhabi [Accessed 18 September 2023].
  3. Department of Health Abu Dhabi. https://www.doh.gov.ae/en/ [Accessed 24 September 2023].
  4. Abu Dhabi Government Entities: Department of Health. https://www.tamm.abudhabi/en/abu-dhabi-government-entities/departmentofhealth [Accessed 24 September 2023].
  5. Authorized Insurance Providers: Department of Health Services. https://www.tamm.abudhabi/wb/doh/authorized-insurance-providers?lang=en [Accessed 24 September 2023].
  6. Department of Health Abu Dhabi: Law and Legislations. https://www.doh.gov.ae/en/about/law-and-legislations [Accessed 24 September 2023].
  7. Encyclopedia of Health Legislation, Book 2: Health Insurance Legislation. Third ed February 2023. 94 p.
  8. Daman Health. https://www.damanhealth.ae/en [Accessed 24 September 2023].
  9. SEHA Abu Dhabi Health Services Company SEHA. https://www.seha.ae [Accessed 1 October 2023].
  10. Abu Dhabi Investment Company ADQ. https://www.adq.ae [Accessed 24 September 2023].
  11. Abu Dhabi ADQ: The Largest Shareholder in PureHealth. https://www.adq.ae/newsroom/adq-to-create-the-uaes-largest-healthcare-platform-by-consolidating-several-companies-within-pure-health/ [Accessed 15 October 2023].
  12. Mubadala Health. https://mubadalahealth.com [Accessed 24 September 2023].
  13. Sheikh Shakhbout Medical City (SSMC). https://ssmc.ae/?utm_source=google_aaa&utm_medium=cpc_aaa&utm_campaign=aaa_brand_competitors_en&gclid=CjwKCAjwr_CnBhA0EiwAci5siq9xXBa19CVuUwfYxncWtbzjwoIf1nUYTT8jqBjMSeUJ--_piTx62xoCOtYQAvD_BwE [Accessed 1 October 2023].
  14. SEHA Abu Dhabi Health Services Company: Media. https://www.seha.ae/media-detail/156#:~:text=Opening%20at%20Sheikh%20Khalifa%20Medical,and%20outcomes%20of%20its%20patients [Accessed 24 September 2023].
  15. Connected Participiants to Malaffi. https://malaffi.ae/connected-participants/ [Accessed 24 September 2023].
  16. Department of Health Circulars. https://www.doh.gov.ae/en/resources/Circulars [Accessed 24 September 2023].
  17. The National Reference Laboratory (NRL). https://nrl.ae [Accessed 29 September 2023].
  18. Purelab’s Transplant Immunology Laboratory. https://mid-east.info/purelabs-transplant-immunology-laboratory-receives-uaes-first-american-society-histocompatibility-and-immunogenetics-ashi-accreditation/ [Accessed 24 September 2023].
  19. Zaman S. Emirati Patient Treated for Lupus with Novel Drug at Tawam Hospital. Gulf News 28 March 2023.
  20. Eight Clinical Programs at Al Ain Hospital Received International Accreditation (article in Arabic). Al Etihad Newspaper 8 May 2018.
  21. UAE Ministry of Economy: The Contribution of the Travel and Tourism Sector to the UAE’s GDP. https://www.moec.gov.ae/en/tourism-indicators [Accessed 24 September 2023].
  22. Department of Health: Centers of Excellence in Abu Dhabi. https://www.doh.gov.ae/en/programs-initiatives/centre-of-excellence [Accessed 24 September 2023].
  23. National Institute for Health Specialties (NIHS). https://nihs.uaeu.ac.ae/en/index.shtml [Accessed 24 September 2023].
  24. Alnaqbi KA, Al Cheikh SA. Shaping the Future: The Transformative Path of the Arab Board of Rheumatology. Cureus 2023;15(9):e45624.
  25. Bonfa E, Gossec L, Isenberg DA, Li Z, Raychaudhuri S. How COVID-19 is changing rheumatology clinical practice. Nat Rev Rheumatol 2021;17(1):11-5.
  26. Arab League of Associations for Rheumatology (ArLAR): COVID-19 and Rheumatic Diseases. https://www.arabrheumatology.org/covid-19 [Accessed 24 September 2023].
  27. Abu Dhabi Health Services Company (SEHA)- eLibrary. https://seha.stacksdiscovery.com/home [Accessed 15 October 2023].
  28. al Attia HM, Gatee OB, George S, Masri MM. Rheumatoid arthritis in a population sample in the Gulf: clinical observations. Clin Rheumatol 1993;12(4):506-10.
  29. al-Attia H, al-Amiri N. HLA-B27 in healthy adults in UAE. An extremely low prevalence in Emirian Arabs. Scand J Rheumatol. 1995;24(4):225-7.
  30. al Attia HM, Sherif AM, Hossain MM, Ahmed YH. The demographic and clinical spectrum of Arab versus Asian patients with ankylosing spondylitis in the UAE. Rheumatol Int 1998;17(5):193-6.
  31. Al Attia HM, Abu Merhi AA, Al Farhan MM. How much do the Arab females know about osteoporosis? The scope and the sources of knowledge. Clin Rheumatol 2008;27(9):1167-70.
  32. Al Attia HM, Santhosh A. A probe into the HLA-DR and DQ of Arab patients with primary antiphospholipid (Hughes) syndrome. Rheumatol Int 2007;28(2):193-5.
  33. Alkindi F ANS, Alseiari K, Alnaqbi KA. Reactive Hip Arthritis and Avascular Necrosis After Severe COVID-19 Infection: A Case Report and Comprehensive Review of Literature. EMJ 2022;7(1):48-55.
  34. Namas R, Abdulla FA, Elarabi M. Intravenous immunoglobulin in the management of refractory lupus profundus. Lupus 2022;31(8):1012-6.
  35. Alfalasi M, ElGhazali G, Fathalla W, Khawaja K. Anti-U1RNP-70kD-positive case of neonatal lupus presenting with seizure and incomplete heart block: a case report and literature review. Front Pediatr 2023;11:1239327.
  36. Elkadry I, Eatamadi H, Sharif E, Khawaja K. The Experience with Uveitis in Paediatric Age Group in Emirate of Abu-Dhabi, United Arab Emirates. J Rheumatol Arthritic Dis 2019;4(1).
  37. Khawaja K, Kalas R, Almasri N. Subtype frequency, demographic features, treatment and outcome of Juvenile Arthritis in one Centre in Abu Dhabi in the United Arab Emirates. Pediatr Rheumatol Online J 2023;21(1):14.
  38. Namas R, Elarabi M, Khan S, Mubashir A, Memisoglu E, El-Kaissi M, et al. Comprehensive description of the prevalence, serological and clinical characteristics, and visceral involvement of systemic sclerosis (scleroderma) in a large cohort from the United Arab Emirates Systemic Sclerosis Registry. J Scleroderma Relat Disord 2023;8(2):137-50.
  39. Alnaqbi KA, Hannawi S, Namas R, Alshehhi W, Badsha H, Al-Saleh J. Consensus statements for evaluation and nonpharmacological Management of Psoriatic Arthritis in UAE. Int J Rheum Dis 2022;25(7):725-32.
  40. Alnaqbi KA, Hannawi S, Namas R, Alshehhi W, Badsha H, Al-Saleh J. Consensus statements for pharmacological management, monitoring of therapies, and comorbidity management of psoriatic arthritis in the United Arab Emirates. Int J Rheum Dis 2022;25(10):1107-22.
  41. Alnaqbi KA, Al Adhoubi N, Al Dallal S, Al Emadi S, Al Herz A, El Shamy A, et al. Consensus Recommendations on the Use of Biosimilars in the Treatment of Inflammatory Arthritis in the Gulf Region. Ann Rheum Dis 2023;82(Suppl 1):2025-6.
  42. Alnaqbi K, Mario E, Samara S. Systematic review examining the available clinical evidence regarding referral, diagnosis, monitoring, and management of axial spondyloarthritis in the Gulf region. PROSPERO 2023 CRD42023403697 Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023403697.
  43. Ahmed S, Grainger R, Santosa A, Adnan A, Alnaqbi KA, Chen YH, et al. APLAR recommendations on the practice of telemedicine in rheumatology. Int J Rheum Dis 2022;25(3):247-58.
  44. Ziade N, Hmamouchi I, El Kibbi L, Daou M, Abdulateef N, Abutiban F, et al. Telehealth in rheumatology: the 2021 Arab League of Rheumatology Best Practice Guidelines. Rheumatol Int 2022;42(3):379-90.
  45. Darzi A, Harfouche M, Arayssi T, Alemadi S, Alnaqbi KA, Badsha H, et al. Adaptation of the 2015 American College of Rheumatology treatment guideline for rheumatoid arthritis for the Eastern Mediterranean Region: an exemplar of the GRADE Adolopment. Health Qual Life Outcomes 2017;15(1):183.
  46. Arayssi T, Harfouche M, Darzi A, Al Emadi S, Alnaqbi KA, Badsha H, et al. Recommendations for the management of rheumatoid arthritis in the Eastern Mediterranean region: an adolopment of the 2015 American College of Rheumatology guidelines. Clin Rheumatol 2018;37(11):2947-59.
  47. Poddubnyy D, Sieper J, Akar S, Munoz-Fernandez S, Haibel H, Hojnik M, et al. Characteristics of patients with axial spondyloarthritis by geographic regions: PROOF multicountry observational study baseline results. Rheumatology (Oxford) 2022;61(8):3299-308.
  48. Alnaqbi KA, Bellanger A, Brill A, Castaneda-Hernandez G, Clopes Estela A, Delgado Sanchez O, et al. An international comparative analysis and roadmap to sustainable biosimilar markets. Front Pharmacol 2023;14:1188368.
  49. Saper VE, Chen G, Deutsch GH, Guillerman RP, Birgmeier J, Jagadeesh K, et al. Emergent high fatality lung disease in systemic juvenile arthritis. Ann Rheum Dis 2019;78(12):1722-31.
  50. Al-Mayouf SM, Almutairi A, Albrawi S, Fathalla B, Alzyoud R, AlEnazi A, et al. Pattern and diagnostic evaluation of systemic autoinflammatory diseases other than familial Mediterranean fever among Arab children: a multicenter study from the Paediatric Rheumatology Arab Group (PRAG). Rheumatol Int 2020;40(1):49-56.
  51. Al-Mayouf S, Hashad S, Khawaja K, Alrasheedi A, Abdwani R, Abushhaiwia A, et al. Cumulative Damage in Juvenile Idiopathic Arthritis: A Multicenter Study From the Paediatric Rheumatology Arab Group. Arthritis Care Res (Hoboken) 2021;73(4):586-92.
  52. Al-Mayouf SM, Alrasheedi A, Almsellati I, Hashad S, Khawaja K, Abdwani R, et al. Familial aggregation of juvenile idiopathic arthritis with other autoimmune diseases: Impact on clinical characteristics, disease activity status and disease damage. Int J Rheum Dis 2021;24(8):1080-5.
  53. Alkwai H, Mirza A, Abdwani R, Asiri A, Bakry R, Alenazi A, et al. Consensus clinical approach for a newly diagnosed systemic juvenile idiopathic arthritis among members of the paediatric rheumatology Arab group. Int J Pediatr Adolesc Med 2021;8(3):129-33.
  54. Alhasni N, Alnaqbi KA, Teir JA. An Audit of Influenza and Pneumococcal Vaccinations in Patients with Rheumatoid Arthritis.  Pan Arab Rheumatology Conference; March 2016; Morocco.
  55. Alnaqbi KA, Al Araimi T, Al Emadi S, Al Rayes H, Saleh K, Bashir K, Baraliakos X. Challenges in referral, diagnosis and management of patients with axial spondyloarthritis. J Rheum Dis 2021;28 (S1):286.
  56. Alnaqbi KA, Aljabri AK. A Case Report of Cardiac Arrhythmia and Heart Failure Shortly After Starting Romosozumab for Osteoporosis: A Coincidence or Association?  World Congress of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases; 4-7 May 2023; Barcelona. p. 681.
  57. Al Nokhatha S, Maguire S, Alnaqbi K. The Effectiveness of IL-23 Inhibitors on Axial Spondyloarthritis and Axial Psoriatic Arthritis: A Systematic Review and Meta-analysis. Ann Rheum Dis 2023;82:1694.
  58. Abuhamed A, Shalaan I, Almarzouqi A, Khawaja K. Onset systemic lupus Erythematosus: A study at a Tertiary Medical Centre in Abu Dhabi. Lupus Sci Med 2023;10(Suppl 2) iii-viii.
  59. Khawaja K, Masalawala M, A. N, Sharif E, Afrooz I, Aljaberi N. The United Arab Emirates Juvenile Idiopathic Arthritis Registry Preliminary Results of Patient Demographics, Subtype distribution, Clinical features, treatment and Outcome. Ann Rheum Dis 2023;82(Suppl 1):1950-1.
  60. Al-Saleh J, Elbadawi F, Namas R, Al-Emadi S, Alnaqbi K, Al-Wahshi H, et al. Demographic and Clinical Characteristics of Patients with LN: A Multicenter Study from the Gulf Region. Arthritis Rheumatol 2023;75(Suppl 9).